• 1
    Casato M, Agnello V, Pucillo LP, Knight GB, Leoni M, Del Vecchio S, et al. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 1997; 90: 386573.
  • 2
    Kunkel HG, Agnello V, Joslin FG, Winchester RJ, Capra JD. Cross-idiotypic specificity among monoclonal IgM proteins with anti-γ-globulin activity. J Exp Med 1973; 37: 33142.
  • 3
    Agnello V, Barnes JL. Human rheumatoid factor cross-idiotypes: WA and BLA are heat-labile conformational antigens requiring both heavy and light chains. J Exp Med 1986; 164: 180914.
  • 4
    Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 14905.
  • 5
    Mazzaro C, Franzin F, Tulissi P, Pussini E, Crovatto M, Carniello GS, et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to α-interferon therapy. Cancer 1996; 77: 260413.
  • 6
    Casato M, Mecucci C, Agnello V, Fiorilli M, Knight GB, Matteucci C, et al. Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia. Blood 2002; 99: 225961.
  • 7
    Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 8994.
  • 8
    De Rosa FG, Agnello V. Observations on cryoglobulin testing: I. The association of cryoglobulins containing rheumatoid factors with manifestation of cryoglobulinemic vasculitis. J Rheumatol 2009; 36: 19535.
  • 9
    Casato M, Agnello V. Mixed cryoglobulinemia syndrome secondary to hepatitis C virus infection. In: National Organization for Rare Disorders guide to rare disorders. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 5.
  • 10
    Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al, for the Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899905.
  • 11
    Agnello V. Mixed cryoglobulinemia and other extrahepatic manifestations of HCV infection. In: Liang, TJ, HoofnagleJH, editors. Hepatitis C. New York: Academic Press, 2000. p. 295313.
  • 12
    Invernizzi F, Galli M, Serino G, Monti G, Meroni LP, Granatieri C. Secondary and essential cryoglobulinemia: frequency, nosological classification and long-term follow-up. Acta Haematol 1983; 70: 7382.
  • 13
    Ohsawa M, Shingu N, Miwa H, Yoshihara H, Kubo M, Tsukama H, et al. Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection. Int J Cancer 1999; 80: 2379.
  • 14
    Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor disease in US veterans with hepatitis C virus. JAMA 2007; 297: 20117.
  • 15
    Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde A, et al, for the Italian Group for the Study of Cryoglobulinaemias. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. QJM 1995; 88: 1156.
  • 16
    Volk ML, Tocco R, Saini S, Lok AS. Public health impact of antiviral therapy for hepatitis C in the United States [published erratum appears in Hepatology 2010;51:725]. Hepatol 2009; 50: 17505.
  • 17
    Knight GB, Agnello V, Bonagura V, Barnes JL, Panka DJ, Zhang QX. Human rheumatoid factor cross-idiotypes. IV. Studies on WA Xid-positive IgM without rheumatoid factor activity provide evidence that the WA Xid is not unique to rheumatoid factors and is distinct from the 17.109 and G6 Xids. J Exp Med 1993; 178: 190311.
  • 18
    Pinheiro G, Knight GB, Agnello V. 1993. GenBank accession numbers U03400 and U03401. URL:
  • 19
    Borretzen M, Randen I, Natvig JB, Thompson KM. Structural restriction in the heavy chain CDR3 of human rheumatoid factors. J Immunol 1995; 155: 36307.
  • 20
    Saadoun D, Suarez F, Lefrere F, Valensi F, Mariette X, Aouba A, et al. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 2005; 05: 746.
  • 21
    Liu X, Hu X, Fan L, Yuan Y. Immunophenotype and ultrastructure of B-cell lymphoproliferative disorder with cytoplasmic projection. J Huazhong Univ Sci Technolog Med Sci 2003; 23: 2368.
  • 22
    Quinn ER, Chan CH, Hadlock KG, Foung SK, Flint M, Levy S. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 2001; 98: 37459.
  • 23
    Stein K, Hummel M, Korbjuhn P, Foss HD, Anagnostopoulos I, Marafioti T, et al. Monocytoid B cells are distinct from splenic marginal zone cells and commonly derive from unmutated naive B cells and less frequently from postgerminal center B cells by polyclonal transformation. Blood 1999; 94: 28008.
  • 24
    Zemlin M, Bauer K, Hummel M, Pfeifer S, Devers S, Zemlin C, et al. The diversity of rearranged immunoglobulin heavy chain variable region genes in peripheral blood B cells of preterm infants is restricted by short third complementarity-determining regions but not by limited gene segment usage. Blood 2001; 97: 15113.
  • 25
    Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291300.
  • 26
    Schifferli JA, French LE, Tissot JD. Hepatitis C virus infection, cryoglobulinemia, and glomerulonephritis. Adv Nephrol Necker Hosp 1995; 24: 10729.
  • 27
    Klein U, Kuppers R, Rajewsky K. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood 1997; 89: 128898.
  • 28
    Franzin F, Efremov DG, Pozzato G, Tulissi P, Batista F, Burrone OR. Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br J Haematol 1995; 90: 54852.
  • 29
    Knight G, Agnello V. WA monoclonal rheumatoid factors and non-Hodgkin lymphoma. Blood 2001; 97: 331921.